Azacytidine for the treatment of retrospective analysis from the Gruppo Laziale for the study of Ph-negative MPN. Issue 8 (August 2015)

• Record Type: Journal Article
• Authors: Andriani, Alessandro; Montanaro, Marco; Voso, Maria Teresa; Villivà, Nicoletta; Ciccone, Fabrizio; Andrizzi, Cristina; De Gregoris, Cinzia; Di Veroli, Ambra; Maurillo, Luca; Alimena, Giuliana; Latagliata, Roberto
• Is Part Of: Leukemia research. Volume 39:Issue 8(2015:Aug.)
• Page Start: 801
• Page End: 804
• Publication Date: 2015-08
• Subjects: Leukemia -- Periodicals; Leukemia -- Periodicals; Leucémie -- Périodiques; Leukemia; Periodicals; Electronic journals; Electronic journals; 616.9941905
• DOI: 10.1016/j.leukres.2015.03.001
• Languages: English
• ISSNs: 0145-2126

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Azacytidine is active in patients with blastic evolution of MPN (complete response 26.3%).</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">The treatment is safe with an acceptable hematologic and extra-hematologic toxicity.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">The overall survival of AZA patients is improved compared to historical controls.</p> </list-item> </list> </p> </sec> </abstract>